Pfizer Inc.
PFE
$25.61
-$0.665-2.53%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
12/31/2023 | 10/01/2023 | 07/02/2023 | 04/02/2023 | 12/31/2022 | |
---|---|---|---|---|---|
Revenue | -41.70% | -31.38% | -23.04% | 0.56% | 23.43% |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | -41.70% | -31.38% | -23.04% | 0.56% | 23.43% |
Cost of Revenue | -30.24% | -36.96% | -36.17% | -19.66% | 12.61% |
Gross Profit | -47.71% | -28.51% | -15.23% | 13.76% | 29.98% |
SG&A Expenses | 13.39% | 19.85% | 33.31% | 40.95% | 27.51% |
Depreciation & Amortization | 31.11% | 33.79% | 18.37% | 5.47% | -2.43% |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | -13.66% | -14.94% | -15.10% | -3.61% | 13.77% |
Operating Income | -86.63% | -56.00% | -35.89% | 8.37% | 42.86% |
Income Before Tax | -96.95% | -68.74% | -29.22% | 15.47% | 42.86% |
Income Tax Expenses | -133.50% | -102.69% | -53.81% | 29.56% | 79.70% |
Earnings from Continuing Operations | -93.08% | -64.95% | -27.00% | 14.24% | 39.82% |
Earnings from Discontinued Operations | -350.00% | 107.14% | 88.51% | 103.60% | 101.38% |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -11.43% | -52.00% | -113.64% | 0.00% | 22.22% |
Net Income | -93.25% | -64.79% | -26.74% | 16.36% | 42.74% |
EBIT | -86.63% | -56.00% | -35.89% | 8.37% | 42.86% |
EBITDA | -73.81% | -47.16% | -30.11% | 7.87% | 35.81% |
EPS Basic | -93.25% | -64.91% | -26.91% | 16.39% | 42.62% |
Normalized Basic EPS | -82.69% | -53.26% | -33.05% | 9.23% | 40.09% |
EPS Diluted | -93.51% | -64.83% | -26.67% | 16.42% | 42.07% |
Normalized Diluted EPS | -82.70% | -52.89% | -32.75% | 9.45% | 39.73% |
Average Basic Shares Outstanding | 0.63% | 0.48% | 0.30% | 0.04% | 0.11% |
Average Diluted Shares Outstanding | -0.86% | -0.55% | -0.27% | -0.13% | 0.43% |
Dividend Per Share | 2.50% | 2.52% | 2.53% | 2.55% | 2.56% |
Payout Ratio | 10.43% | 1.18% | 0.40% | -0.12% | -0.28% |